Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

OSI Systems, Inc. (OSIS) SEC Filings & Earnings Calls

EquiReason read 11 OSI Systems, Inc. SEC filings in the last 12 months. Latest: 10-K on 2026-08-21 — OSIS reported fiscal 2026 annual results with revenue growth of 4.2% to $1.786B, gross margin decline to 33.2%, and strong operating cash flow of $275.9M..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OSISOSI Systems, Inc.Follow OSIS — free
Electronic Components · Technology
—
Price chart with a free account
Market cap
3.1B
P/E TTM
21.9
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

21 Aug 202610-KOSIS reported fiscal 2026 annual results with revenue growth of 4.2% to $1.786B, gross margin decline to 33.2%, and strong operating cash flow of $275.9M.earningsopen

Figures in the filing · each found in the filing text

Total Net Revenues · FY2026$1.79B+4% y/y
Security Net Revenues · Security · FY2026$1.25B+4% y/y
Optoelectronics / Manufacturing Net Revenues · Optoelectronics / Manufacturing · FY2026$375M+8% y/y
Healthcare Net Revenues · Healthcare · FY2026$163M-3% y/y
Gross Profit · FY2026$593M+1% y/y
Gross Margin · FY202633.2%
Selling, general and administrative · FY2026$278M-4% y/y
Research and development · FY2026$79M+8% y/y
Impairment, restructuring and other charges · FY2026$17M+213% y/y
Interest and other expense, net · FY2026$26M-17% y/y

Risks flagged

Convertible Note Dilution

“upon conversion of the 2.25% Convertible Senior Notes due 2029 (the “2029 Notes”) or the 0.50% Convertible Senior Notes due 2031 (the “2031 Notes”), collectively the “Notes”, may dilute the ownership interest of our stockholders or may adversely affect the market price of our common stock.” · word for word

Healthcare Revenue Decline

“Revenues for the Healthcare division during the fiscal year ended June 30, 2026 decreased by $5.6 million year-over-year due primarily to a reduction in patient monitoring sales of $9.6 million” · word for word

Geopolitical Disruption

“The conflicts in the Middle East had an impact on our operating results in the fourth quarter of fiscal year 2026 through delays in timing of shipments, customer acceptance procedures, project schedules, and new orders.” · word for word

Memory Component Cost Pressure

“We have experienced tighter supply conditions and increased costs for certain memory associated and semiconductor components, reflecting a broader global imbalance between supply and demand for memory used in data center and AI related infrastructure.” · word for word

Trade Policy Uncertainty

“Tariffs, trade restrictions and retaliatory measures by such other countries could result in revenue reductions for the Company or cost increases on material used in our products, which could materially and adversely affect our business, financial condition, results of operations and cash flows.” · word for word
Read the original on SEC EDGAR ↗
20 Aug 20268-K · 2.02, 8.01OSI Systems Board approved additional 1M shares for repurchase, increasing total authorization to 1,078,731 shares. Also reported record FY2026 revenue $1.79B, record non-GAAP EPS $10.35, record backlog $1.9B, record operating cash flow $27open

Figures in the filing · each found in the filing text

Revenues · FY2026$1.79B+4% y/y
Diluted earnings per share - GAAP · FY2026$8.95+3% y/y
Diluted earnings per share - non-GAAP · FY2026$10.35+11% y/y
Cash flow provided by operating activities · FY2026$276M+183% y/y
Capital expenditures · FY2026$31M+28% y/y
Backlog · Q4-2026$1.90B+6% y/y
Cash and cash equivalents · Q4-2026$360M+238% y/y
Q4 Revenues · Q4-2026$484M-4% y/y
Q4 Diluted earnings per share - GAAP · Q4-2026$3.27+8% y/y
Q4 Diluted earnings per share - non-GAAP · Q4-2026$3.78+17% y/y

Guidance

FY2027 revenue $1.875-1.930B (5.0-8.1% YoY growth); non-GAAP EPS $11.13-11.49 (7.5-11.0% YoY growth)

Company introduces FY2027 guidance with revenue and EPS growth, reflecting confidence in demand and operational execution.

Risks flagged

Revenue headwinds from Middle East conflicts caused delivery delays; though not cancellations, they introduce uncertainty.

“Despite the impact of revenue headwinds from the Middle East conflicts which shifted the timing of certain planned deliveries.” · word for word

Q4 revenue declined 4% YoY due to these disruptions, though backlog remains strong.

“Revenues $484,058 (in thousands) for Q4 FY2026 vs $504,985 for Q4 FY2025, a -4% change.”
Read the original on SEC EDGAR ↗
4 May 202610-QTotal net revenues $453M (+2% y/y); Security division revenue $319M (+1% y/y); Optoelectronics and Manufacturing division revenue $93M (+9% y/y)open

Figures in the filing · each found in the filing text

Total net revenues · Q3-2026$453M+2% y/y
Security division revenue · Security · Q3-2026$319M+1% y/y
Optoelectronics and Manufacturing division revenue · Optoelectronics and Manufacturing · Q3-2026$93M+9% y/y
Healthcare division revenue · Healthcare · Q3-2026$41M-7% y/y
Gross profit · Q3-2026$150M0% y/y
Cash and cash equivalents · 2026-03-31$345M

Risks flagged

Tariff and trade policy risk

“Tariffs and trade restrictions and retaliatory measures by such other countries could result in revenue reductions for the Company or cost increases on material used in our products.” · word for word

Semiconductor supply constraint

“We have experienced tighter supply conditions and increased costs for certain memory associated and semiconductor components, reflecting a broader global imbalance between supply and demand for memory used in data center and AI related infrastructure.” · word for word

Hospital capital spending pressure

“Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs. To the extent macroeconomic conditions remain challenging, it is likely that hospitals’ spend on capital equipment will be adversely impacted.” · word for word

Geopolitical and government shutdown risk

“Ongoing military conflicts and geopolitical tensions in the Middle East, including involving Iran, may adversely affect global markets, energy prices, supply chain reliability, transportation networks, customer demand, and investor confidence, which could materially impact demand for our products and services from our customers, timing of delivery of product” · word for word
Read the original on SEC EDGAR ↗
4 May 20268-K · 2.02Revenues $453M (+2% y/y); Diluted earnings per share - GAAP $2.33 (-3% y/y); Diluted earnings per share - non-GAAP $2.60 (+7% y/y); Guidance: Revenue $1.825B-$1.867B; Non-GAAP EPS $10.30-$10.55earningsopen

Figures in the filing · each found in the filing text

Revenues · Q3-2026$453M+2% y/y
Diluted earnings per share - GAAP · Q3-2026$2.33-3% y/y
Diluted earnings per share - non-GAAP · Q3-2026$2.60+7% y/y
Backlog · Q3-2026$1.90B
Book-to-Bill Ratio · Q3-2026$1.30
Cash flow provided by operating activities · Q3-2026$14M-82% y/y
Capital expenditures · Q3-2026$8M+67% y/y

Guidance

Revenue $1.825B-$1.867B; Non-GAAP EPS $10.30-$10.55

Reiterated FY2026 guidance; record backlog and strong bookings support demand acceleration; margin expansion in Security division.

Risks flagged

DHS shutdown and Middle East conflicts could impact near-term bookings and revenues.

“impact on near-term bookings and revenues of the recent shutdown of the Department of Homeland Security and current conflicts in the Middle East” · word for word

Operating cash flow declined significantly in Q3 vs prior year.

“Cash flow provided by operating activities $14,457 vs $81,642 in prior year Q3”
Read the original on SEC EDGAR ↗
29 Jan 20268-K · 2.02Revenues $464M (+11% y/y); GAAP Diluted EPS $2.22 (+0% y/y); Non-GAAP Diluted EPS $2.58 (+7% y/y); Guidance: FY2026 non-GAAP EPS guidance raised to $10.30-$10.55 (10-13% YoY growth)earningsopen

Figures in the filing · each found in the filing text

Revenues · Q2-2026$464M+11% y/y
GAAP Diluted EPS · Q2-2026$2.220% y/y
Non-GAAP Diluted EPS · Q2-2026$2.58+7% y/y
Operating Cash Flow · Q2-2026$62M
Backlog · Q2-2026$1.80B

Guidance

FY2026 non-GAAP EPS guidance raised to $10.30-$10.55 (10-13% YoY growth)

Raised FY2026 non-GAAP EPS guidance while maintaining revenue guidance; expects continued growth from backlog and opportunity pipeline

Risks flagged

Security division bookings softer than expected due to U.S. government shutdown delaying orders

“Bookings were softer than expected, partly due to the U.S. government shutdown delaying receipt of certain anticipated orders” · word for word

Security division margins lower due to difficult year-over-year comparison

“Margins were lower given a difficult year-over-year comparison” · word for word
Read the original on SEC EDGAR ↗
29 Jan 202610-QQ2 fiscal 2026 results: total revenue +10.5% YoY, Security strong, Healthcare weak, gross margin down 230bps.earningsopen

Figures in the filing · each found in the filing text

Total net revenues · Q2-2026$464M+11% y/y
Security division revenue · Security · Q2-2026$335M+15% y/y
Optoelectronics and Manufacturing division revenue · Optoelectronics and Manufacturing · Q2-2026$93M+9% y/y
Healthcare division revenue · Healthcare · Q2-2026$37M-19% y/y
Gross profit · Q2-2026$152M+3% y/y
Gross margin · Q2-202632.7%
Cash and cash equivalents · 2025-12-31$337M
Operating cash flow · YTD Q2-2026$79M+415% y/y
Capital expenditures · YTD Q2-2026$14M+4% y/y

Risks flagged

Healthcare division revenue decline

“Revenues for the Healthcare division during Q2 fiscal 2026 decreased year-over-year primarily due to a decrease in patient monitoring sales.” · word for word

Gross margin pressure from product mix

“The gross margin decreased as compared to the prior year comparable period as the prior year period had a favorable mix of Security division product revenues.” · word for word

Tariff and trade policy uncertainty

“Tariffs and trade restrictions and retaliatory measures by such other countries could result in revenue reductions for the Company or cost increases on material used in our products.” · word for word
Read the original on SEC EDGAR ↗
20 Nov 20258-K · 1.01, 2.03, 3.02Entered a material definitive agreement (acquisition, partnership, or major contract); took on a material direct financial obligation, increasing leverageopen

Risks flagged

Potential dilution from conversion of notes into equity.

“Convertible Senior Notes due 2031.” · word for word
Read the original on SEC EDGAR ↗
18 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Potential equity dilution if notes are converted; low coupon indicates strong credit profile.

“0.50% Convertible Senior Notes due 2031” · word for word
Read the original on SEC EDGAR ↗
17 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Potential dilution from conversion of notes into common stock.

“shares of the Company’s common stock, if any, issuable upon conversion of the Notes” · word for word

Increased leverage from new debt issuance.

“Convertible Senior Notes due 2031” · word for word
Read the original on SEC EDGAR ↗
30 Oct 202510-QOSI Systems reported Q1 fiscal 2026 revenue of $384.6M (+11.8% YoY) with strong growth across all divisions, but gross margin declined 330 bps due to product mix.earningsopen

Figures in the filing · each found in the filing text

Net Revenue · Q1-2026$385M+12% y/y
Security Division Revenue · Security · Q1-2026$254M+13% y/y
Optoelectronics and Manufacturing Division Revenue · Optoelectronics and Manufacturing · Q1-2026$90M+9% y/y
Healthcare Division Revenue · Healthcare · Q1-2026$41M+10% y/y
Gross Profit · Q1-2026$123M+1% y/y
Operating Cash Flow · Q1-2026$17M
Cash and Equivalents · 2025-09-30$124M

Risks flagged

Government Shutdown Impact

“A prolonged shutdown could delay the issuance of government contracts or the processing of existing contracts, particularly in our Security division, issuances of export licenses, shipments, deliveries and payments of invoices.” · word for word

Hospital Capital Spending Slowdown

“Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs and higher interest rates make access to credit more expensive. To the extent macroeconomic conditions remain challenging, it is likely that hospitals’ spend on capital equipment will be adversely impacted.” · word for word

Tariff Cost Exposure

“Tariffs and trade restrictions and retaliatory measures by such other countries could result in revenue reductions for the Company or cost increases on material used in our products.” · word for word

Geopolitical Conflict Disruption

“The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict as well as the Israel-Hamas conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources.” · word for word
Read the original on SEC EDGAR ↗
30 Oct 20258-K · 2.02Revenues $385M (+12% y/y); Diluted earnings per share - GAAP $1.18 (+12% y/y); Diluted earnings per share - non-GAAP $1.42 (+14% y/y); Guidance: Revenue guidance raised from $1.805B-$1.850B to $1.825B-$1.867B; Non-GAAP EPS guidance raised fearningsopen

Figures in the filing · each found in the filing text

Revenues · Q1-2026$385M+12% y/y
Diluted earnings per share - GAAP · Q1-2026$1.18+12% y/y
Diluted earnings per share - non-GAAP · Q1-2026$1.42+14% y/y
Book-to-Bill Ratio · Q1-2026$1.10
Cash flow provided by operating activities · Q1-2026$17M
Capital expenditures · Q1-2026$7M
Security division revenue growth · Security · Q1-202613.0%
Optoelectronics and Manufacturing division revenue growth · Optoelectronics and Manufacturing · Q1-202612.0%
Healthcare division revenue growth · Healthcare · Q1-202610.0%

Guidance

Revenue guidance raised from $1.805B-$1.850B to $1.825B-$1.867B; Non-GAAP EPS guidance raised from $10.11-$10.39 to $10.20-$10.48.

Raised FY2026 revenue and non-GAAP EPS guidance driven by strong Q1 results, record backlog, and broad-based demand across all segments.

Risks flagged

Dependence on global demand and macroeconomic conditions could impact future growth.

“Forward-looking statements caution about factors that could cause actual results to differ.”
Read the original on SEC EDGAR ↗

OSI Systems, Inc. — questions

What did OSI Systems, Inc. file recently?
11 SEC filings in the last 12 months. Latest: 10-K on 2026-08-21 — OSIS reported fiscal 2026 annual results with revenue growth of 4.2% to $1.786B, gross margin decline to 33.2%, and strong operating cash flow of $275.9M.

Every figure on this page comes from OSI Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.